Squamous Cell Carcinoma Antigen (SSCA)
Squamous cell carcinoma antigen (SCC-Ag) is a tumor-associated antigen that can be detected in blood. It has been most studied in patients with Squamous Cell Carcinoma (SCC) of the cervix or lung, however, it has also been associated with SCCs involving the head/neck or oral cavity, as well as non-cancerous conditions such as erythroderma, sarcoidosis, psoriasis, eczema and lichen planus.
It has been suggested as both a prognostic factor and monitoring tool in cervical SCC, although it’s use has not been adopted by the NCCN or other medical societies.
- Treatment monitoring and management of squamous cell carcinoma of the skin, head and neck, lung, and cervix
- Diseases prognosis and survival
Increased in:
- Cervical cancer neoplasms
- Non-small cell lung cancer
- Carcinoma of the head and neck
- Benign inflammatory conditions of the skin
- Sarcoidosis
Male: < or =2.00 mcg/L
Females: < or =1.67 mcg/L
Immunofluorescent Assay (IFA), Immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST) tube.
Stability
- Ambient – 3-5 days
- Refrigerated - -14 days
- Frozen - 90 days
Carcinoembryonic antigen test, Pap smear, Complete blood count with differential count, skin punch biopsy.
1-3 days.
- Dis Markers. 2019 Jun 2;2019:6710352. [PMID: 31275450]
- Cancer. 1989 Oct 15;64(8):1652-6. [PMID: 2790678]
- Radiat Oncol. 2019 Aug 15;14(1):146. [PMID: 31416463]
- Br J Cancer. 2018 Jan;118(1):72-78. [PMID: 29112685]
- J Exp Clin Cancer Res. 2000 Dec;19(4):477-81. [PMID: 11277326]
- Gynecol Oncol. 1997 Mar;64(3):418-24. [PMID: 9062143]
- Int J Cancer. 2005 Sep 10;116(4):579-83. [PMID: 15825162]